CTLA4Ig-gene transfection with FTY720 administration markedly inhibits the obliterative airway disease in heterotopically transplanted rat tracheas.
Kita
Y
Y
Department of Thoracic Surgery, Haibara General Hospital, Shizuoka, Japan.
Li
X-K
XK
Nogimura
H
H
Ida
M
M
Kageyama
Y
Y
Ohi
S
S
Suzuki
K
K
Kazui
T
T
Suzuki
S
S
D000069594:Abatacept; D000818:Animals; D003131:Combined Modality Therapy; D000068876:Fingolimod Hydrochloride; D018796:Immunoconjugates / Q000235:genetics* / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D023421:Models, Animal; D011184:Postoperative Period; D011409:Propylene Glycols / Q000627:therapeutic use*; D051381:Rats; D011917:Rats, Inbred Lew; D011919:Rats, Inbred Strains; D011994:Recombinant Proteins / Q000627:therapeutic use; D013110:Sphingosine / Q000031:analogs & derivatives; D013997:Time Factors; D014132:Trachea / Q000473:pathology / Q000637:transplantation*; D014162:Transfection / Q000379:methods*; D016042:Transplantation, Heterotopic; D014184:Transplantation, Homologous / Q000276:immunology* / Q000379:methods / Q000473:pathology
D018796:Immunoconjugates; D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D011994:Recombinant Proteins; D000069594:Abatacept; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine